SCHEMBL3145506

SCHEMBL3145506

O=C(Nc1cccc(-c2nc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4)cc3o2)c1)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.61
LMNA P02545 1/20 0.61
MAPT P10636 10/20 0.59
SMN1; SMN2 Q16637 4/20 0.58
KDM4E B2RXH2 3/20 0.58
POLB P06746 2/20 0.58
THRB P10828 1/20 0.57
HSD17B10 Q99714 2/20 0.56
ALDH1A1 P00352 2/20 0.56
USP2 O75604 1/20 0.56
PKM P14618 1/20 0.56
HPGD P15428 1/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
PTGS2 P35354 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4526536 0.88 LMNA (0.79) TP53LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL4504150 0.85 TP53 (0.54) TP53LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL4501249 0.85 HPGD (0.72) TP53LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL2242896 0.83 MAPT (0.73) TP53LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL4512212 0.82 TP53 (0.65) TP53LMNAMAPTSMN1; SMN2POLB
SCHEMBL4526889 0.80 TP53 (0.59) TP53LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL2242280 0.79 MAPT (0.84) TP53LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL16291851 0.79 MAPT (0.85) TP53MAPTSMN1; SMN2KDM4EPOLB
SCHEMBL4055488 0.79 MAPT (0.77) TP53LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL2244232 0.78 KDM4E (0.80) TP53MAPTSMN1; SMN2KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004301-A1 Benzoxazoles Useful in the Treatment of Inflammation BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004301-A1 Benzoxazoles Useful in the Treatment of Inflammation IL4I1, EPX, IL4 TP53 2523/4885LMNA 1694/4885MAPT 270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.